The drugs in therapy of chronic idiopathic thrombocytopenic purpura:romiplostim and eltrombopagYAO Yuan-bing, WANG Ling, XIA Yue, JIN Gui-lan2221-2225,2239
Pharmaceutical research and development investment in China:problems and contermeasuresSUN Yan, SUN Li-hua2226-2230
A comparison of innovative drug research and development abilities between China and foreign countries based on an evaluation system of pharmaceutical technology innovationYAO Xue-fang, DING Jin-xi, SHAO Rong, CHENG Can2231-2239
Analysis of the revision of Chinese Patent Law and its detailed regulation of implementation: main points and influences on pharmaceutical enterprisesZHANG Qing-kui2240-2243
Bayesian mixed treatment comparisons and implementation using WinBUGSLIAO Wei-qi, CHEN Ping-yan2244-2248
Common problems and status on drug registration application dossier (1) :regulatory informationFENG Yi, LIU Lu, XIAO Hui-lai, TIAN Heng-kang, CHENG Lu-rong2249-2250,2253
Common problems and status on drug registration application dossier (2) : pharmaceutical study of chemical drugsLIU Lu, CHENG Lu-rong, XIAO Hui-lai, TIAN Heng-kang, FENG Yi2251-2253
Common problems and status on drug registration application dossier (3) : pharmaceutical study of Traditional Chinese MedicinesTIAN Heng-kang, XIAO Hui-lai, CHENG Lu-rong, LIU Lu, FENG Yi2254-2254,2260
Common problems and status on drug registration application dossier (4) : pharmacological and toxicological studiesCHENG Lu-rong, XIAO Hui-lai, TIAN Heng-kang, LIU Lu, FENG Yi2255-2257